Washington, D.C. | November 1, 2017 – Stumphauzer & Sloman partner Ryan Stumphauzer will speak on November 1, 2017, about criminal and civil enforcement actions against compounding pharmacies at the Health Care Compliance Association’s (HCCA) Third Annual Healthcare Enforcement Compliance Institute in Washington, DC. Mr. Stumphauzer, along with Assistant United States Attorney Jason Mehta, will discuss how the government uses various fraud enforcement statutes, such as the False Claims Act and the Anti-Kickback Statute, to target compounding pharmacists, marketers, and executives, who engage in various schemes to defraud government agencies such as the Department of Defense’s TRICARE Program. The panel will review and summarize the government’s past enforcement actions, and identify the particular fact patterns that have attracted the government’s scrutiny including the payment of research fees and/or medical director fees to prescribing physicians, employment opportunities and other incentives offered to prescribing physicians’ family members, percentage -based commission payments to marketers, waivers of patient co-pays, kickbacks to patients in the form of untraceable gift cards, as well as mass telemarketing schemes. The panelists will also summarize and discuss the facts of several recent cases where the government has prosecuted compounding pharmacists, marketers, and executives based on unlawful dispensing and promotion of compounded drugs.
If you are the target of a government investigation or would like to learn more about recent government actions surrounding compounding pharmacy, please contact the attorneys at Stumphauzer & Sloman.
